• Amiodarone hydrochloride, a benzofurane derivative used for the treatment of cardiac arrhythmias, is known to cause a verticillate epithelial keratopathy, which has been classified into three stages. Patients receiving low dosages of 100 to 200 mg of amiodarone daily retain clear corneas or show stage 1 changes only, regardless of duration of treatment or total amount of substance ingested. Patients receiving higher dosages of 400 to 1,400 mg/day show stage 2 and 3 changes, depending on duration of treatment. This keratopathy progresses, even with reduced dosage; however, complete regression occurs once administration of medication is discontinued.
Kaplan LJ, Cappaert WE. Amiodarone Keratopathy: Correlation to Dosage and Duration. Arch Ophthalmol. 1982;100(4):601–602. doi:10.1001/archopht.1982.01030030603011
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: